Search

everythinglearnresearchcommunity

for

Search:↓

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

A young woman had a rare, aggressive ovarian tumor that was hard to diagnose and treat, leading to disease progression despite treatment.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Other common signs, not just the well-known immune cells around hair bulbs, are important for diagnosing hair loss from alopecia areata.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Hair loss in male pattern baldness involves muscle degeneration and increased scalp fat.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Hair loss due to syphilis can be identified using trichoscopy and is treatable with antibiotics.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Vertical sections are better than horizontal sections for diagnosing alopecia.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

A kidney transplant patient on cyclosporin experienced unexpected severe hair loss, which improved with treatment adjustments.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The document provides a method to classify human hair growth stages using a model with human scalp on mice, aiming to standardize hair research.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

The document concludes that understanding hair follicle cell cycles is crucial for hair growth and alopecia research, and recommends specific techniques and future research directions.

Aging alone rarely causes significant hair loss; hormones are a bigger factor.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).